- Home
- ORLA vs SDGR Comparison
ORLA vs SDGR Comparison
Compare ORLA & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORLA
- SDGR
- Stock Information
- Founded
- ORLA 2007
- SDGR 1990
- Country
- ORLA Canada
- SDGR United States
- Employees
- ORLA N/A
- SDGR N/A
- Industry
- ORLA Precious Metals
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- ORLA Basic Materials
- SDGR Health Care
- Exchange
- ORLA Nasdaq
- SDGR Nasdaq
- Market Cap
- ORLA 1.6B
- SDGR 1.6B
- IPO Year
- ORLA N/A
- SDGR 2020
- Fundamental
- Price
- ORLA $5.75
- SDGR $19.00
- Analyst Decision
- ORLA Buy
- SDGR Buy
- Analyst Count
- ORLA 2
- SDGR 10
- Target Price
- ORLA $6.13
- SDGR $32.90
- AVG Volume (30 Days)
- ORLA 585.4K
- SDGR 624.0K
- Earning Date
- ORLA 11-12-2024
- SDGR 02-26-2025
- Dividend Yield
- ORLA N/A
- SDGR N/A
- EPS Growth
- ORLA N/A
- SDGR N/A
- EPS
- ORLA 0.01
- SDGR N/A
- Revenue
- ORLA $314,101,000.00
- SDGR $193,348,000.00
- Revenue This Year
- ORLA $45.12
- SDGR N/A
- Revenue Next Year
- ORLA $71.13
- SDGR $26.50
- P/E Ratio
- ORLA $418.21
- SDGR N/A
- Revenue Growth
- ORLA 38.09
- SDGR N/A
- 52 Week Low
- ORLA $3.02
- SDGR $16.67
- 52 Week High
- ORLA $6.05
- SDGR $33.63
- Technical
- Relative Strength Index (RSI)
- ORLA 55.88
- SDGR 43.08
- Support Level
- ORLA $5.38
- SDGR $18.63
- Resistance Level
- ORLA $5.93
- SDGR $20.20
- Average True Range (ATR)
- ORLA 0.25
- SDGR 1.00
- MACD
- ORLA -0.03
- SDGR -0.15
- Stochastic Oscillator
- ORLA 56.52
- SDGR 19.14
About ORLA Orla Mining Ltd.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Mexico, and the South Railroad and Lewis gold projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.